DOES EARLY IMMUNOSUPPRESSIVE THERAPY PREVENT SYSTEMIC SCLEROSIS ASSOCIATED INTERSTITIAL LUNG DISEASE?

被引：0
|
作者：
Velauthapillai, A. [1 ]
Bootsma, M. [1 ]
Bruni, C. [2 ]
Distler, O. [2 ]
Van den Ende, C. [1 ]
Vonk, M. [1 ]
机构：
[1] Radboud Univ Nijmegen, Rheumatol, Med Ctr, Nijmegen, Netherlands
[2] Univ Hosp Zurich, Rheumatol, Zurich, Switzerland
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Systemic sclerosis; Lungs; Epidemiology;
D O I：
10.1136/annrheumdis-2023-eular.1277
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0239
引用
收藏
页码：159 / 160
页数：2
相关论文
共 50 条
  • [1] IMMUNOSUPPRESSIVE THERAPY IN SYSTEMIC SCLEROSIS ASSOCIATED INTERSTITIAL LUNG DISEASE-SYSTEMATIC REVIEW
    Nandagudi, Anupama
    Kingsley, Gabriella
    Scott, David
    Stratton, Richard
    RHEUMATOLOGY, 2010, 49 : I113 - I113
  • [2] Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group
    Sabine Adler
    Dörte Huscher
    Elise Siegert
    Yannick Allanore
    László Czirják
    Francesco DelGaldo
    Christopher P. Denton
    Oliver Distler
    Marc Frerix
    Marco Matucci-Cerinic
    Ulf Mueller-Ladner
    Ingo-Helmut Tarner
    Gabriele Valentini
    Ulrich A. Walker
    Peter M. Villiger
    Gabriela Riemekasten
    Arthritis Research & Therapy, 20
  • [3] Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group
    Adler, Sabine
    Huscher, Dorte
    Siegert, Elise
    Allanore, Yannick
    Czirjak, Laszlo
    DelGaldo, Francesco
    Denton, Christopher P.
    Distler, Oliver
    Frerix, Marc
    Matucci-Cerinic, Marco
    Mueller-Ladner, Ulf
    Tarner, Ingo-Helmut
    Valentini, Gabriele
    Walker, Ulrich A.
    Villiger, Peter M.
    Riemekasten, Gabriela
    ARTHRITIS RESEARCH & THERAPY, 2018, 20
  • [4] Preventive effects of early immunosuppressive treatment on the development of interstitial lung disease in systemic sclerosis
    Velauthapillai, Arthiha
    Bootsma, M. F. R.
    Bruni, Cosimo
    Bergmann, Christina
    Matucci-Cerinic, Marco
    Launay, David
    Riemekasten, Gabriela
    Garzanova, L.
    Airo, Paolo
    Rezus, Elena
    da Silva, Jose A. P.
    Del Galdo, Francesco
    Hunzelmann, Nicolas
    Chung, Lorinda S.
    Krasowska, Dorota
    Distler, Oliver
    van den Ende, Cornelia H. M.
    Vonk, Madelon C.
    RHEUMATOLOGY, 2024,
  • [5] Association Between Immunosuppressive Therapy and Incident Risk of Interstitial Lung Disease in Systemic Sclerosis
    Hoa, Sabrina
    Bernatsky, Sasha
    Baron, Murray
    Proudman, Susanna
    Stevens, Wendy
    Sahhar, Joanne
    Wang, Mianbo
    Steele, Russell J.
    Nikpour, Mandana
    Hudson, Marie
    CHEST, 2021, 160 (06) : 2158 - 2162
  • [6] Association between immunosuppressive therapy and course of mild interstitial lung disease in systemic sclerosis
    Hoa, Sabrina
    Bernatsky, Sasha
    Steele, Russell J.
    Baron, Murray
    Hudson, Marie
    RHEUMATOLOGY, 2020, 59 (05) : 1108 - 1117
  • [7] Modern drug therapy for systemic sclerosis associated interstitial lung disease
    Aringer, Martin
    Koschel, Dirk
    Krause, Andreas
    Schneider, Udo
    Glaeser, Sven
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2022, 147 (04) : 179 - 186
  • [8] Interstitial Lung Disease Associated with Systemic Sclerosis
    Mismetti, Valentine
    Si-Mohamed, Salim
    Cottin, Vincent
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 45 (03) : 342 - 364
  • [9] Systemic Sclerosis Associated Interstitial Lung Disease
    Steen, Virginia
    Weir, Nargues
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2015, 11 (02) : 110 - 118
  • [10] Systemic sclerosis associated interstitial lung disease
    Xanthouli, P.
    Hermann, W.
    Hunzelmann, N.
    Kreuter, M.
    PNEUMOLOGE, 2018, 15 (06): : 383 - 395
12345